 |
dextromethorphan hydrobromide/quinidine sulfate |
|---|---|
| Trade Name | Nuedexta |
| Orphan Indication | Amyotrophic lateral sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2017-02-14 00:00:00 |
| Sponsor | Avanir Pharmaceuticals;30 Enterprise, Suite 400;Aliso Viejo, California, 92656 |
